Answers are grounded in this paper and cite their sources.
273.5%), indicating effective siRNA delivery and target suppression. A mathematical model incorporating macrophage-mediated siEphA2-LNP transport, with or without nab-PTX, was developed to evaluate treatment schedules under varying tumor microenvironment conditions. Collectively, these findings highlight the potential for tailoring macrophage-mediated EphA2-siRNA-LNP therapy for BCLM based on patient-specific tumor characteristics.
No takes yet. Share an insight, caveat, or question.
Tiwari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: